Clinical Trial Update: The Effect of Nicotine on Arousal, Cognition and Social Cognition in Schizophrenic Patients [EARLY_Phase 1]

View source ↗

Summary

Early-phase clinical trial evaluating the effects of nicotine on arousal, cognition, and social cognition in individuals with schizophrenia; the study status is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Disorders
• Schizophrenia

Drugs mentioned

• Nicotine (nicotine)

Snippet

Sponsor: Janssen Pharmaceutica N.V., Belgium | Conditions: Schizophrenia, Cognition Disorders | EARLY_Phase 1 | Status: COMPLETED